Page last updated: 2024-09-03

7-benzylamino-6-chloro-2-piperazino-4-pyrrolidinopteridine and Cancer of Liver

7-benzylamino-6-chloro-2-piperazino-4-pyrrolidinopteridine has been researched along with Cancer of Liver in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Biagioni, S; Cardarelli, S; Cifone, MG; Cinque, B; Galli, F; Giardi, MF; Giorgi, M; Massimi, M; Panera, N; Ragusa, F1

Other Studies

1 other study(ies) available for 7-benzylamino-6-chloro-2-piperazino-4-pyrrolidinopteridine and Cancer of Liver

ArticleYear
Increase of Intracellular Cyclic AMP by PDE4 Inhibitors Affects HepG2 Cell Cycle Progression and Survival.
    Journal of cellular biochemistry, 2017, Volume: 118, Issue:6

    Topics: Carcinoma, Hepatocellular; Cell Cycle; Cell Cycle Proteins; Cell Proliferation; Cell Survival; Cyclic AMP; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Liver Neoplasms; Phosphodiesterase 4 Inhibitors; Piperazines; Pteridines; Rolipram

2017